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Research
Arsenite is an environmental toxicant that has 
been associated with numerous human health 
problems, including dermatosis, diabetes melli-
tus, cardio  vascular disorders, and cancer (Tapio 
and Grosche 2006). Epidemiologic evidence 
implicates exposure to arsenite in causing 
human cancers of the skin, lung, and bladder 
[International Agency for Research on Cancer 
(IARC) 2004]. Although skin is thought to 
be the most sensitive site for arsenite toxic-
ity, the lung is now recognized as a specific 
target (Chen et al. 2004). In vitro, arsenite 
causes malignant transformation of various 
cells, including human keratinocytes and small 
airway epithelial cells (Pi et al. 2008; Wen et al. 
2008). Arsenite induces tumorigenesis by acti-
vating signal pathways and transcription fac-
tors, such as mitogen-activated protein kinases, 
activating factor-1, and nuclear factor-κB 
(NF-κB), which are involved in promoting 
cell proliferation and malignant transformation 
(Huang et al. 2004; Salnikow and Zhitkovich 
2008). Although arsenite is carcinogenic, the 
mechanisms involved remain unclear.
In mammalian cells, p53 (often called 
the “guardian of the genome”) is involved 
in the maintenance of genome stability. 
In response to diverse cellular stresses, p53 
protein transactivates downstream target genes 
required for DNA repair, cell cycle arrest, and 
apoptosis (Pietsch et al. 2008). People carrying 
one dysfunctional p53 gene in their germ  line 
have a high probability of developing a tumor. 
Restoration of p53 function inhibits ultra-
violet B–induced skin carcinogenesis. Thus, 
functional inactivation of p53 is a common 
charac  teristic of tumors (Konstantakou et al. 
2009; Lim and Park 2009). Involved in the 
inactivation of p53 are the following mecha-
nisms: a) mutations of p53 that eliminate its 
function in DNA binding or transcriptional 
activation; b) abnormal expression of p53-in-
teracting proteins (e.g., mdm2), which results 
in accelerated degradation of wild-type p53 or 
in stabilization of mutant p53; and c) nuclear 
exclusion of wild-type p53 (Huang et al. 2008; 
Wadhwa et al. 2002). Although the first two 
categories have been investigated intensively, 
the third remains poorly understood.
Data relating to the effects of arsenite on 
p53 are conflicting. Although high levels of 
arsenite generally induce an increase in p53 
activity in response to arsenite-induced DNA 
damage, lower levels yield results that are 
dependent on the compound, concentration, 
duration of treatment, and cell type (Bodwell 
et al. 2004; Pi et al. 2005). Apparently, the 
tumor suppressor function of p53 must be 
compromised before a cell undergoes arsenite-
mediated transformation (Aylon and Oren 
2007; Kastan 2007). p53 dysfunction is neces-
sary for arsenite-induced centrosome abnor-
malities and transformation in human lung 
cells (Liao et al. 2007). Defining the molecu-
lar mechanism of p53 inactivation in arsenite-
induced neoplastic transformation of cells is 
necessary for a complete understanding of the 
onco  genesis caused by arsenite. In the pres-
ent study, we exposed human embryo lung 
fibroblast (HELF) cells to low levels of arsen-
ite [see Supplemental Material, Figure 1A 
(doi:10.1289/ehp.0901677)] to investigate 
underlying mechanisms of arsenic-mediated 
effects on p53 function and neoplastic trans-
formation of these cells.
Materials and Methods
Cells, cell culture, and arsenite exposure. 
The HELF cell line and A549 cell line were 
obtained from the Shanghai Institute of 
Cell Biology, Chinese Academy of Sciences 
(Shanghai, China). HELF cells are human 
sarcoma virus-40 (SV-40) immortalized 
and non  tumorigenic diploid fibroblasts 
from lungs of hysterotomy-derived embryos 
(Hayflick and Moorhead 1961). HELF cells 
have normal p53 function and signal path-
ways and are used as a model of lung dam-
age and neo  plastic transformation induced 
by environmental agents (Gao et al. 2007; 
Jiao et al. 2008; Wang et al. 2005). A549 
cells, human lung adenocarcinoma epithelial 
cells, are often used as positive controls in 
lung cancer research. Cells were cultured as 
described previously (He et al. 2007). For 
chronic exposure, 1 × 106 cells were seeded 
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Ba c k g r o u n d: Inactivation of p53 is involved in arsenite-induced tumorigenesis; however, the 
molecular mechanisms remain poorly understood.
oB j e c t i v e: We investigated the molecular mechanisms underlying the inactivation of p53 and neo-
plastic transformation induced by arsenite in human embryo lung fibroblast (HELF) cells. 
Me t h o d s : Anchorage-independent growth assays were performed, and tumorigenicity in intact 
animals was assessed to confirm arsenite-induced neoplastic transformation. We determined the 
levels and functions of p53, nuclear factor-kappa B (NF-κB; a key transcriptional regulator), and 
mot-2 (a p53 inhibitor) and their relationships in arsenite-induced transformed HELF cells by 
two-dimensional electrophoresis, reverse-transcriptase polymerase chain reaction, Western blot, 
immuno  fluorescence, and co-immunoprecipitation assays. 
re s u l t s: Exposure of HELF cells to low levels of arsenite increased their proliferation rate and 
anchorage-independent growth and disrupted normal contact inhibition. When introduced into 
nude mice, transformed cells were tumorigenic. We used proteomic analysis to identify proteins with 
altered expression between untreated and arsenite-exposed cells. We found decreased expression of 
NF-κB repressing factor (NKRF; an inhibitor of NF-κB–mediated gene transcription), increased 
expression of mot-2, and increased activation of NF-κB. Changes in cells exposed to 1.0 µM arsenite 
were more marked than changes in cells exposed to 0.5 or 2.0 µM arsenite. Inactivation of NF-κB 
prevented malignant transformation induced by 1.0 µM arsenite. Moreover, we also identified a 
mechanism whereby NF-κB regulated p53. Specifically, activation of NF-κB up-regulated mot-2 
expression, which prevented nuclear translocation of p53 and switched the binding preference of the 
p53 and NF-κB coactivator CBP [cyclic AMP-responsive element binding protein (CREB) binding 
protein] from p53 to NF-κB.
co n c l u s i o n s: mot-2–mediated cross talk between NF-κB and p53 appears to be involved in arsenite-
induced tumorigenesis of HELF cells.
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into 10-cm (diameter) dishes for 24 hr and 
maintained in 0.0, 0.5, 1.0, or 2.0 µM 
sodium arsenite (NaAsO2; Sigma, St. Louis, 
MO, USA; 99.0% purity) for 48–72 hr per 
passage. This process was continued for about 
15 weeks (30 passages). The NF-κB inhib-
itor Bay11-7082 (Sigma) was dissolved in   
dimethyl sulfoxide (Sigma). All other reagents 
used were of analytical grade or the highest 
grade available.
Serum starvation. We routinely cultured 
2 × 104 cells in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) in six-well plates for 
24 hr. For serum starvation, the medium was 
changed to 1% FBS. After 96 hr, the cells, in 
triplicate, were collected and counted under a 
microscope.
Anchorage-independent growth. Soft 
agar dishes were prepared with underlayers 
of 0.70% agarose in DMEM supplemented 
with 10% FBS. To test for soft-agar colony 
growth capacity, cells were plated in triplicate 
at a density of 1 × 104 in 2 mL 0.35% agarose 
over the agar base. Cultures were fed every 
3 days; after 14 days, colonies with > 30 cells 
were examined microscopically.
Tumorigenicity in intact animals. This 
study was performed according to a protocol 
approved by the Nanjing Medical University 
Institutional Animal Care and Use Committee, 
and animals were treated humanely and with 
regard for alleviation of suffering. Briefly, 
1 × 107 cells were injected subcutaneously into 
the right armpit of nude BALB/c mice 6 (six 
mice per group). Four weeks later, the tumor 
tissues were removed, fixed with 4% formalin, 
embedded in paraffin, sectioned, stained with 
hematoxylin and eosin, and analyzed by light 
microscopy.
Analysis of cellular protein level altera-
tions. Differences in levels of cellular proteins 
between passage control cells and transformed 
cells were detected by two-dimensional elec-
trophoresis (2DE). Detection of protein 
spots, in-gel tryptic digestion, mass spectrom-
etry, and statistical analysis were performed as 
described previously (Zhang et al. 2007).
RNA interference. We purchased con-
trol small interfering RNA (siRNA), RelA 
siRNA, and p53 siRNA from Cell Signaling 
Technology (Beverly, MA, USA). The 
oligo  nucleotides for mot-2 siRNA were 
5´-GGAUUGUCACUGAUCUAAU-3´ 
and 5´-AUUAGAUCAGUGACAAUCC-3´ 
(Sigma). We performed cell transfections using 
the N-TER Nanoparticle siRNA Transfection 
System (Sigma). Briefly, 7 × 105 cells were 
seeded into each well of six-well plates, 
18–24 hr before transfection. Nanoparticle 
formation solution containing 20 nM tar-
get gene siRNA was added to transfection 
medium and transferred to each well of the 
culture plates. After 24 hr, cells were harvested 
for Western blot, co-immuno  precipitation, or 
immuno    staining assays.
Reverse-transcriptase polymerase chain 
reaction (RT-PCR). Total RNA (2 µg) was 
transcribed into cDNA using AMV Reverse 
Transcriptase (Promega, Madison, WI, 
USA). We used mot-2 primers (forward, 
5´-CGAGTCAGATTGGAGCAT-3´; reverse, 
5´-GACCATAGGCAAGAGCAG-3´) for 
PCR amplification.
Immunostaining. Treated cells were 
incubated with rabbit phospho-p53 (p-p53) 
antibody (Cell Signaling Technology) at 4°C 
overnight and then incubated with Cy3-
conjugated goat anti-rabbit secondary antibody 
(Millipore, Billerica, MA, USA) for 1 hr. The 
nuclei were stained by adding 4´,6-diamidino-
2-phenylindole (DAPI; Sigma) for 10 min. 
The cells were observed under a fluorescence 
microscope (Olympus, Tokyo, Japan). We 
analyzed fluorescence intensities using a mul-
timode microplate reader (Tecan Trading AG, 
Männedorf, Switzerland) and images with an 
Image-Pro Plus 6.0 (Olympus).
Western blots. Cell lysates were separated by 
SDS-PAGE and transferred to polyvinylidene 
fluoride membranes (Millipore); the immune 
complexes were detected by enhanced chemi-
luminescence (Cell Signaling Technology). 
We used the following antibodies: NF-κB 
repressing factor (NKRF), CBP [cyclic AMP 
responsive element binding protein (CREB) 
binding protein], mot-2 (a p53 inhibitor), and 
β-actin (all from Sigma); and NF-κB inhibi-
tor (IκBα), phosphorylated IκBα [p-IκBα 
(serine 32)], RelA (a subunit of NF-κB), phos-
phorylated RelA (p-RelA; serine 536), wild-
type p53, p-p53 (serine 15), and proliferating 
cell nuclear antigen (PCNA) (all from Cell 
Signaling Technology). Blots were quantitated 
by densitometry and normalized using β-actin 
to correct for differences in protein loading. 
For densitometric analyses, we measured pro-
tein bands on the blot using Eagle Eye II soft-
ware (He et al. 2007).
Co-immunoprecipitation. Cells were 
extracted for 30 min with lysis buffer. After 
centrifugation of the preparations, the super-
natants were incubated with p53 or CBP anti-
body and subsequently with A+G Sepharose 
beads (Sigma) at 4°C overnight. The pellets 
were washed three times, resuspended in the 
SDS sample buffer, and boiled to remove pro-
tein from the beads. The immunoprecipitants 
were analyzed by Western blots with mot-2, 
RelA, or p53 antibodies.
Statistical analysis. All numeral data, 
except tumor incidence and tumor volumes, 
were generated from three independent 
experi  ments and expressed as mean ± SD. We 
used one-way analysis of variance (ANOVA) 
to assess significant differences among groups. 
Statistical significance, determined by the 
Fisher test, was set at p < 0.05. 
Results
Neoplastic transformation of HELF cells 
induced by arsenite. To evaluate oncogenic 
transformation, we exposed HELF cells to 0.0, 
0.5, 1.0, or 2.0 µM arsenite. After 15 weeks, 
the passage control cells grew in a mono-
layer, showed the typical elongated shape of 
fibroblast-like cells, and stopped dividing 
after reaching confluence. In contrast, trans-
formed cells showed an epithelial-like mor-
phology; after reaching confluence, they grew 
in multi  layers and formed cellular aggregates 
(Figure 1A). The doubling time of the passage 
control cells was 27.6 ± 2.1 hr; the values for 
transformed cells induced by 0.5, 1.0, and 
2.0 µM arsenite were 22.8 ± 2.6, 22.3 ± 2.1, 
and 22.7 ± 1.7 hr, respectively. The levels of 
PCNA in transformed cells were higher than 
in passage control cells [see Supplemental 
Material,  Figure  1B  (doi:10.1289/
ehp.0901677)]. Moreover, transformed cells 
tolerated low levels of serum (Figure 1B). 
In agar, 552 ± 84, 689 ± 71, and 598 ± 83 
colonies were formed in HELF cells exposed 
to 0.5, 1.0, and 2.0 µM arsenite, respec-
tively, and 449 ± 43 colonies were formed in 
A549 cells. In contrast, passage control cells 
showed no anchorage-independent growth 
(Figure 1C,D). 
In the nude BALB/c mice injected with 
HELF cells exposed to 0.5, 1.0, and 2.0 µM 
arsenite and in the positive control mice 
injected with A549 carcinoma cells, tumor 
incidences were all 100% (6 of 6 per group); 
for the passage control group, however, the 
incidence was 0% (0 of 6). Tumors induced 
by arsenite-transformed cells consisted of 
either highly undifferentiated or spindle cells. 
The tumor volumes for the groups implanted 
with cells exposed to 0.5, 1.0, and 2.0 µM 
arsenite were 0.73 ± 0.59, 2.29 ± 1.23, and 
1.79 ± 0.98 cm3, respectively, and 1.26 ± 0.31 
cm3 for the A549 positive-control group 
(Figure 1E,F).
Identification of proteins differentially 
expressed in arsenite-induced transformed 
HELF cells. Of 5,671 protein spots, 126 were 
different between the passage control cells and 
transformed cells [see Supplemental Material, 
Figure 2A,B (doi:10.1289/ehp.0901677)]. Of 
these, we selected NKRF (an NF-κB inhibitor) 
and mot-2 (a p53 inhibitor) for further analy-
sis. The NKRF in transformed cells was 73% 
lower than in passage control cells; mot-2 in 
transformed cells was 110% higher than in pas-
sage control cells [see Supplemental Material, 
Figure 2C (doi:10.1289/ehp.0901677)]. 
Verifying the results of 2DE, Western blots 
confirmed the down-expression of NKRF and 
up-expression of mot-2 in transformed cells. 
However, these changes in the 1.0-µM arsenite 
group were more marked than those for the 0.5- 
or 2.0-µM arsenite groups. Further, p-RelA, 
which indicates the activation of NF-κB, was Li et al.
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Figure 1. Neoplastic transformation of HELF cells exposed to 0.0, 0.5, 1.0, or 2.0 µM arsenite (As) for about 15 weeks (30 passages). C, control (untreated) HELF cells. 
A549 carcinoma cells served as the positive control. Morphological images of cells (A) after culture with 10% FBS (bars = 500 µm) and (B) after culture with 1% FBS 
(bars = 50 µm). (C) Photomicrographs of cell colonies in soft agar; bars = 500 µm. (D) The number (mean ± SD) of cell colonies in soft agar (n = 3). (E) Representative 
pathological sections of tumors 4 weeks after cells were inoculated into nude/BALB/c mice; tumors induced by arsenite-transformed cells consisted of undifferen-
tiated and spindle cells (bars = 100 µm). (F) Volume (mean ± SD) of tumors in nude/BALB/c mice (n = 6). 
*p < 0.01 compared with control group. **p < 0.05 compared with 0.5 or 2.0 µM arsenite groups. #p < 0.05 compared with mice implanted with cells exposed to 0.5 µM arsenite. 
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higher in transformed cells than in passage con-
trol cells (Figure 2A,B). With increased time of 
exposure to arsenite, we found more malignant 
cells and greater down-expression of NKRF 
and up-expression of p-RelA and mot-2. No 
such changes, however, were observed in pas-
sage control cells (Figure 2C,D).
NF-κB activation as a regulator of mot-2 in 
arsenite-exposed HELF cells. Based on the pres-
ent results, which showed NF-κB activation 
and accompanying increases of mot-2 during 
arsenite-induced neoplastic transformation, and 
the fact that the sequence GGAGGTTTCC 
of the mot-2 promoter is similar to kap-
paB DNA elements (GGGRNYYYCC) 
[see Supplemental Material, Figure 3A 
(doi:10.1289/ehp.0901677)], we investi-
gated the possibility that the mot-2 increases 
were caused by NF-κB activation. The levels 
of p-IκBα, p-RelA, and mot-2 were elevated 
by 1.0 µM arsenite. However, inhibition of 
NF-κB by Bay11-7082 [a compound that 
blocks IκBα phosphorylation and consequently 
prevents nuclear translocation of the activated 
NF-κB complex; see Supplemental Material, 
Figure 3B,C (doi:10.1289/ehp.0901677)] or 
RelA siRNA (which inhibits translation of the 
RelA NF-κB subunit) blocked the arsenite-
induced increases of mot-2 protein and mRNA 
levels (Figure 3A,B).
Involvement of NF-κB and mot-2 in the 
activation and translocation of p53 in arsenite-
treated HELF cells. Because mot-2 negatively 
regulates p53 activation (Wadhwa et al. 2002) 
and because NF-κB activation enhances mot-2 
expression (Figure 3), there could be mot-2-
–mediated cross talk between NF-κB and p53 
in arsenite-exposed HELF cells. Blockage of 
NF-κB (by Bay11-7082 or Rel-A siRNA) or 
mot-2 (by mot-2 siRNA) further increased the 
1.0 µM arsenite-induced elevation of p-p53 
but not of p53, which indicated arsenite-in-
duced elevation of nuclear p53 (p-p53) but 
not of cytosolic (transcriptionally inactive) p53 
(Figure 4A,B). In parallel with these results, 
inhibition of either NF-κB or mot-2 increased 
the nuclear translocation of p53 induced by 
1.0 µM arsenite (Figure 4C,D).
mot-2–mediated cross talk between NF-κB 
and p53 in arsenite-exposed HELF cells. 
Arsenite increased the binding of mot-2 to p53, 
which was attenuated by blocking of NF-κB 
activity (Figure 5A,B). Furthermore, in mot-
2–normal cells with a blocked NF-κB signal 
pathway, 1.0 µM arsenite promoted binding of 
the CBP coactivator to p53 instead of NF-κB; 
the change, however, was not evident in mot-2-
–knockdown cells (Figure 5C,D).
Role of NF-κB in arsenite-induced 
neoplastic transformation of HELF cells. 
During transformation, Bay11-7082 effec-
tively blocked arsenite-induced NF-κB 
activation [see Supplemental Material, 
Figure 4 (doi:10.1289/ehp.0901677)]. After 
15 weeks of culture in agar, 724 ± 106 and 
496 ± 41 colonies were formed from HELF 
cells exposed to 1.0 µM arsenite and from 
A549 carcinoma cells, respectively. In con-
trast, unexposed HELF cells and HELF 
cells exposed to Bay11-7082 with or with-
out 1.0 µM arsenite showed no anchorage- 
independent growth (Figure 6A,B). In mice 
injected with arsenite–exposed cells (1.0 µM) 
and mice injected with A549 carcinoma 
cells, tumor incidences were 100% (6 of 6 
per group); tumor incidences for the other 
three groups were 0% (0 of 6 per group). 
Tumor volumes were 2.63 ± 1.99 cm3 and 
1.76 ± 0.96 cm3 in animals implanted with 
HELF cells exposed to 1.0 µM arsenite or 
with A549 cells respectively (Figure 6C,D).
Figure 2. The levels of NKRF and mot-2 and the activation of NF-κB in HELF cells transformed by arsenite (As). β-Actin levels, measured in parallel, served as 
controls. (A) Levels of NKRF, p-RelA, RelA, and mot-2 in HELF cells exposed to 0.0, 0.5, 1.0, or 2.0 µM arsenite for about 15 weeks (30 passages) as detected by 
Western blots. (B) Relative protein levels (mean ± SD) of NKRF, p-RelA, and mot-2 (n = 3). (C) Western blot analyses of NKRF, mot-2, p-RelA, and RelA in HELF cells 
exposed to 0.0 µM (top) or 1.0 µM (bottom) arsenite for 1, 5, 10, 15, 20, 25, or 30 passages. (D) Relative protein levels (mean ± SD) of NKRF, p-RelA, and mot-2 in 
passage control cells (top) and in cells exposed to 1.0 µM arsenite (bottom); n = 3. 
*p < 0.01 compared with passage control cells. **p < 0.05 compared with cells exposed to 0.5 or 2.0 µM arsenite. 
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No mutations of p53 in neoplastic transfor-
mation of HELF cells induced by arsenite. In 
transformed HELF cells, the DNA sequences 
of exons 1–10 were a 100% match to p53 
cDNA after DNA fragments including exons 
1–10 of p53 were sequenced using primers of 
PCR amplification [see Supplemental Material, 
Figure 5 (doi:10.1289/ehp.0901677)].
Discussion
Inorganic arsenite is a widely distributed, natu-
rally occurring environmental contaminant 
affecting tens of millions of people worldwide 
(IARC 2004). Chronic exposure to low lev-
els of arsenite (< 5 µM) usually causes cell 
prolifera  tion, which leads to neoplastic trans-
formation, whereas high levels cause cytotoxic-
ity, indicating that the cellular effects of arsenite 
are dependent on the degree of exposure (Shen 
et al. 2008; Wen et al. 2008). In the present 
study, repeated exposure of HELF cells to 0.5, 
1.0, or 2.0 µM arsenite resulted in neoplastic 
transformation of these cells, as determined by 
anchorage-independent growth in soft agar and 
tumori  genesis in nude mice.
In the United States and China, the current 
maximum contaminant level for arsenite in 
drinking water is 10 µg/L (~ 0.5 µM) (Huang 
et al. 2008). Therefore, in this study, we used 
0.5, 1.0, and 2.0 µM concentrations of arsenite 
for long-term exposure of HELF cells. These 
levels of arsenite do not cause cell death and 
are lower than levels in drinking water in areas 
where arsenicosis is common (Pi et al. 2002; 
Tokar et al. 2010). Further, for cells exposed to 
1.0 µM arsenite, the numbers of colonies and 
the volumes of tumors that developed in nude 
Figure 3. Effects of blocking NF-κB on mot-2 protein and mRNA levels and NF-κB activation in HELF 
cells exposed to arsenite (As). HELF cells were exposed to 10 µM Bay11-7082 (Bay) for 3 hr or to 20 nM 
control (Con) siRNA or RelA siRNA for 24 hr, then incubated with 0.0 or 1.0 µM arsenite for 3 hr (p-IκBα 
and p-RelA) or 24 hr (mot-2, IκBα, and RelA). β-Actin levels, measured in parallel, served as controls. (A) 
Western blot analyses of mot-2, p-IκBα, IκBα, p-RelA, and RelA (top), and RT-PCR analyses of mot-2 (bot-
tom). (B) Relative protein or mRNA levels of mot-2 (mean ± SD; n = 3). 
##p < 0.01 compared with cells exposed to arsenite plus Bay11-7082 or arsenite plus RelA siRNA. 
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Figure 4. Involvement of NF-κB and mot-2 in the activation and translocation of p53 in HELF cells exposed to arsenite (As). HELF cells were exposed to 10 µM 
Bay11-7082 (Bay) for 3 hr or to 20 nM control (Con) siRNA, RelA siRNA, or mot-2 siRNA for 24 hr, then incubated with 0.0 or 1.0 µM arsenite for 3 hr (p-p53, p-IκBα, 
and p-RelA) or 24 hr (p53, mot-2, RelA, and IκBα); fluorescence intensities were analyzed with a multimode microplate reader. β-Actin levels, measured in paral-
lel, served as controls. (A) Western blot analyses of p-p53, p53, mot-2, p-RelA, RelA, p-IκBα, and IκBα. (B) Relative protein levels (mean ± SD) of p-p53, p53, and 
mot-2 (n = 3). (C) Immunofluorescence staining for p53 localization in HELF cells: blue, DAPI staining for nuclear DNA; red, p-p53. Bar, 25 µm. (D) Relative intensity 
(mean ± SD) of nuclear p53 fluorescence (n = 3). 
##p < 0.05 compared with cells exposed to arsenite plus Bay11-7082, arsenite plus RelA siRNA, or arsenite plus mot-2 siRNA. 
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mice were higher than corresponding values 
for the 0.5 and 2.0 µM arsenite-exposed cells; 
this is in accord with the cell proliferation rate 
induced by 1.0 µM arsenite, which was higher 
than that induced by 0.5 or 2.0 µM arsenite. 
Therefore, the neoplastic transformation of 
HELF cells induced by low levels of arsenite is 
apparently associated with cell proliferation.
For this study, we selected HELF cells 
for assessing the p53 response to low levels of 
arsenite because these cells have a normal p53 
function and normal signal pathways and are 
used as a model of lung damage and neoplas-
tic transformation induced by environmental 
agents (Gao et al. 2007; Jiao et al. 2008; Wang 
et al. 2005). Biomethylation activates arsen-
ite as a toxin and a carcinogen (Kojima et al. 
2006; Sakurai et al. 2006). Because the capac-
ity of HELF cells for arsenite biomethylation 
is unknown, the transformative agent in this 
study could have been inorganic arsenite, a 
methylated metabolite, or a combination of 
inorganic and methylated metabolites. 
Interference by arsenite of the activation 
of p53 via poly-ADP-ribosylation may be 
involved in its comutagenic and cocarcino-
genic effects (Yu et al. 2008). Because in this 
study we found no mutations of p53 but did 
observe disruption of p53 function in trans-
formed HELF cells, the low levels of arsenite 
apparently induced the dysfunction of p53 via 
a signal pathway.
NF-κB activation is thought to initiate 
and accelerate tumorigenesis, and its inhibition 
blocks cell transformation induced by tumor 
promoters (Li et al. 1997; Perkins 2007). 
Reactive oxygen stress, induced by low concen-
trations of arsenite (< 5 µM), activates NF-κB 
(Wijeweera et al. 2001). Data in the present 
study show that low levels of arsenite increase 
IκBα phosphorylation (thereby promoting 
nuclear translocation of NF-κB) and RelA 
Figure 6. Involvement of NF-κB in arsenite-induced tumorigenesis in HELF cells exposed for about 15 weeks (30 passages) to 0.0 or 1.0 µM arsenite (As), to 10 µM 
Bay11-7082 (Bay), or to arsenite plus Bay11-7082. A549 cells served as the positive control (Con). (A) Cell colonies in soft agar; bars = 500 µm. (B) Number of cell colo-
nies in soft agar (mean ± SD; n = 3). (C) Representative pathological sections of tumors 4 weeks after cells were inoculated into nude/BALB/c mice. Tumors induced 
by arsenite-transformed cells were composed of undifferentiated and spindle cells; bars = 100 µm. (D) Volume (mean ± SD) of tumors in nude/BALB/c mice (n = 6). 
*p < 0.01 compared with control cells, Bay11-7082 cells, or arsenite plus Bay11-7082 cells. 
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Figure 5. mot-2–mediated cross talk between NF-κB and p53 in HELF cells exposed to arsenite (As). 
(A) Western blot analyses of mot-2 and p53 after cell lysates were subjected to co-immunoprecipitation with 
p53 (IP) and mot-2 (IB) antibodies. HELF cells were exposed to 10 µM Bay11-7082 for 3 hr or to 20 nM control 
(Con) siRNA or RelA siRNA for 24 hr, then incubated with 0.0 or 1.0 µM arsenite for 24 hr. (B) Relative protein 
levels (mean ± SD) of mot-2 (n = 3). (C) Western blot analyses of RelA, p53, and CBP after cell lysates were 
subjected to co-immunoprecipitation with CBP (IP) and RelA or p53 (IB) antibodies. After mot-2–normal or 
mot-2–defective HELF cells were exposed to 10 µM Bay11-7082 for 3 hr, they were incubated with 0.0 or 
1.0 µM arsenite for 24 hr. (D) Relative protein levels of RelA and p53 (mean ± SD; n = 3). 
##p < 0.05 compared with cells exposed to arsenite plus Bay11-7082 or arsenite plus RelA siRNA. †p < 0.05 compared 
with corresponding arsenite exposure in mot-2–knockdown cells. ††p < 0.05 compared with corresponding arsenite and 
Bay11-7082 exposure in mot-2–knockdown cells. 
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phosphorylation, indicating that activation of 
NF-κB is accomplished by classical signaling 
pathways in arsenite-induced transformation.
mot-2, which is expressed in many cell 
types and tissues, possesses diverse activi-
ties, including oncogenic transformation. 
Moreover, many human transformed and 
tumor-derived cells have high mot-2 expres-
sion (Wadhwa et al. 1999, 2002). mot-2 
inactivates p53 function by directly binding 
to its C-terminal amino acid residues (Kaul 
et al. 2005). In human cells, mot-2 levels are 
increased by ionizing radiation and ozone 
(Wu et al. 1999). However, the mechanisms 
by which mot-2 exerts its effects remain 
unclear. In the present study, low levels of 
arsenite caused increases of mot-2 mRNA 
and protein levels, but this effect was not evi-
dent for cells in which NF-κB activation was 
blocked. This indicates that the NF-κB signal 
pathway is involved in mot-2 expression in 
arsenite-exposed HELF cells. The data also 
indicate that mot-2, regulated by NF-κB acti-
vation, was involved in the cross talk between 
NF-κB and p53 in arsenite-transformed 
HELF cells. In contrast, decreases in NKRF, 
increases in p-RelA and mot-2, and increases 
in cell colony numbers in soft agar and tumor 
volumes in nude mice induced by 1.0 µM 
arsenite were more pronounced than those 
caused by 0.5 or 2.0 µM arsenite. Moreover, 
blocking of NF-κB in HELF cells prevented 
the increase in mot-2, nuclear translocation of 
p53, and neoplastic transformation induced 
by 1.0 µM arsenite.
Cross talk between NF-κB and p53 nega-
tively regulates their activities by competing 
for limiting pools of the p300 and CBP coacti-
vators, which are required by both NF-κB and 
p53 for transactivation (Webster and Perkins 
1999). IKKα-mediated phosphorylation of 
CBP switches the protein-binding preference 
of CBP from p53 to NF-κB and results in 
concurrent up-regulation of NF-κB–mediated 
genes and down-regulation of p53-mediated 
genes; this leads the cell toward tumori  genesis 
(Huang et al. 2007). The present results 
also show that, in mot-2–normal cells with a 
blocked NF-κB signal pathway, 1.0 µM arsen-
ite increased CBP binding to p53 instead of 
binding to NF-κB; the change, however, was 
not evident in mot-2–knockdown cells.
Conclusion
In arsenite-induced neoplastic transforma-
tion of HELF cells, activation of NF-κB 
increases mot-2 expression by regulating 
its transcription. As a negative regulator of 
p53, mot-2 prevents p53 from translocating 
to the nucleus and functionally disables this 
tumor suppressor, which results in switching 
the binding preference of CBP from p53 to 
NF-κB. Our results expand the understand-
ing of the carcinogenic potential of arsenite 
by identifying a mechanism whereby NF-κB 
regulates p53. Our results also illustrate how 
arsenite inactivates p53 to lead to neoplastic 
transformation of HELF cells.
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